Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity C0022658|renal disease
Sentences 16
PubMedID- 22773754 From our results in poko mice at 4 weeks of age, we define the poko mouse as a good model for the study of the initiation and progression of renal disease associated with metabolic syndrome and glucolipotoxicity.
PubMedID- 20702470 Background: the disorders associated with metabolic syndrome (ms) can lead to renal disease.
PubMedID- 21780055 Patients and methods: between august 2003 and august 2009, 11 patients underwent selective percutaneous transarterial renal embolization for end stage renal disease associated with uncontrolled hypertension, nephrotic syndrome, bleeding or malignancy.
PubMedID- 21961334 Aim: to study the role of lipid metabolism impairment in renal disease in patients with metabolic syndrome associated with obesity.
PubMedID- 24744899 Further, increasing adiponectin levels by targeting the action of ang ii may be a logical and promising approach for the treatment of cardiovascular and renal diseases associated with metabolic syndrome or diabetes.
PubMedID- 22532116 This review focuses on the importance of the transcription factors peroxisome proliferator-activated receptor alpha, peroxisome proliferator-activated receptor beta, peroxisome proliferator-activated receptor gamma, liver x receptors, farnesoid x receptor, and the pregnane x receptor/steroid and xenobiotic receptor (pxr) on the physiology and pathophysiology of renal diseases associated with obesity and metabolic syndrome.
PubMedID- 25991066 In the present study, the relationship between inadequate serum concentrations of vitamin d and metabolic syndrome in patients with end-stage renal disease undergoing hemodialysis was explored.
PubMedID- 24601848 It has not been elucidated if the concomitant presence of t2dm or metabolic syndrome with end-stage renal disease further impairs the atherogenic profiles.
PubMedID- 20729743 Secondary amyloidosis may complicate chronic inflammatory conditions and mostly presents as a renal disease with nephrotic syndrome or renal insufficiency.
PubMedID- 22829804 First, the drugs currently used to successfully retard the progression of cardiovascular and renal disease in patients with the metabolic syndrome all have strong direct antioxidant effects.
PubMedID- 22909024 Nephrotic syndrome may persist in patients with end-stage renal disease (esrd) and require therapeutic intervention to stop diuresis.
PubMedID- 20071464 Recent studies suggest that the metabolic syndrome is associated with renal disease.
PubMedID- 20490358 The obese zucker rat is a model for human metabolic syndrome with associated renal disease [22, 23].
PubMedID- 25984106 Nevertheless, recurrent relapses and therapy-resistant nephrotic syndrome leading to end-stage renal disease may occur [5].
PubMedID- 26538831 Influence of malondialdehyde and matrix metalloproteinase-9 on progression of carotid atherosclerosis in chronic renal disease with cardiometabolic syndrome.
PubMedID- 24574628 So far as underlying renal disease and setting of syndrome complex is considered among these patients, six patients (55%) had acute renal failure (four had hus, one had pauci-immune crescentic gn, one had solitary functioning kidney obstructed by a stone who developed pres in setting of post-obstructive diuresis and associated persistent hypocalcemia), four patients (36%) had normal renal function [one patient with diffuse proliferative lupus nephritis and uncontrolled hypertension, one patient of focal segmental glomerulosclerosis (fsgs) with high trough level of cyclosporine 300 ng/ml, one patient with mpgn who developed hypertensive encephalopathy due to non-compliance to medication, one with morbid nephrotic state with scrotal skin necrosis and severe hypoproteinemia (serum albumin 1.1 gm/dl)].

Page: 1